Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/19/2013 | US8586362 Method for DNA double-strand break repair in vitro and applications thereof |
11/19/2013 | US8586361 FRT recombination sites and methods of use |
11/19/2013 | US8586358 HLA homozygous cells |
11/19/2013 | US8586355 Embryo sac-specific genes |
11/19/2013 | US8586354 Adenoviruses, nucleic acids that code for the same and the use of said viruses |
11/19/2013 | US8586350 Mechanism of separating and purifying DNA and the like |
11/19/2013 | US8586346 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
11/19/2013 | US8586339 Facilitated process for purification of proteins |
11/19/2013 | US8586336 Nucleic acid molecule encoding xylose isomerase and xylose isomerase encoded by the nucleic acid molecule |
11/19/2013 | US8586334 Method for producing substance utilizing microorganism |
11/19/2013 | US8586332 Method for producing oligopolysaccharides |
11/19/2013 | US8586328 Method for producing sclareol |
11/19/2013 | US8586327 Detection of bacteria belonging to the genus Campylobacter by targeting cytolethal distending toxin |
11/19/2013 | US8586326 Molecules involved in protein folding |
11/19/2013 | US8586317 Methods of diagnosing hypophosphatemic disorders |
11/19/2013 | US8586312 Methods of using an array of pooled probes in genetic analysis |
11/19/2013 | US8586311 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
11/19/2013 | US8586309 Methods of determining copy number of a genetic locus |
11/19/2013 | US8586298 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
11/19/2013 | US8586297 Modulating the Cdc14B-Cdh1-Plk1 axis and methods for sensitizing target cells to apoptosis |
11/19/2013 | US8586295 Method for screening HIV drug sensitivity |
11/19/2013 | US8586293 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
11/19/2013 | US8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571 |
11/19/2013 | US8586037 Antibodies against IL-17BR |
11/19/2013 | US8586032 Use of alkaline phosphatase in the treatment of reduced renal function |
11/19/2013 | US8586031 Method of reusing rinse water from disinfecting packages with peracid and catalase |
11/19/2013 | US8586028 Synthetic herpes simplex viruses type-1 for treatment of cancers |
11/19/2013 | US8586022 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
11/19/2013 | DE202013006982U1 Plasmid-Vektor zur Anreicherung und zur Analyse von Zellen mit aktiviertem Wnt-Signalweg Plasmid vector for enrichment and analysis of cells with Wnt signaling pathway is activated |
11/19/2013 | CA2707235C Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
11/19/2013 | CA2703533C Polynucleotides and methods for making plants resistant to fungal pathogens |
11/19/2013 | CA2609062C Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm |
11/19/2013 | CA2593520C Recombinant expression of proteins in a disulfide-bridged, two-chain form |
11/19/2013 | CA2592366C Recombinant foot and mouth disease vaccine |
11/19/2013 | CA2587507C Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
11/19/2013 | CA2581224C Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
11/19/2013 | CA2554966C Methods and compostions for targeted cleavage and recombination |
11/19/2013 | CA2548805C Light-controlled electrokinetic assembly of particles near surfaces |
11/19/2013 | CA2511475C Immunostimulatory sequence oligonucleotides and methods of using the same |
11/19/2013 | CA2502636C Diagnosis of shwachman-diamond syndrome |
11/19/2013 | CA2486450C Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles |
11/19/2013 | CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
11/19/2013 | CA2454300C Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
11/19/2013 | CA2447139C Specific binding proteins and uses thereof |
11/19/2013 | CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
11/19/2013 | CA2434845C Hepatitis c virus replicons and replicon enhanced cells |
11/19/2013 | CA2411694C Furin polypeptides with improved characteristics |
11/19/2013 | CA2404890C Rna sequence-specific mediators of rna interference |
11/19/2013 | CA2398083C Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
11/19/2013 | CA2383217C Lysosomal targeting pathway enzymes |
11/19/2013 | CA2353866C Treatment of papillomavirus infections |
11/19/2013 | CA2346996C Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
11/19/2013 | CA2329757C Use of .alpha.1.beta.1 integrin receptor inhibitors and tgf-.beta.1 inhibitors in the treatment of kidney disease |
11/19/2013 | CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
11/14/2013 | WO2013170265A1 Methods for high yield production of terpenes |
11/14/2013 | WO2013170258A2 Rhg1 mediated resistance to soybean cyst nematode |
11/14/2013 | WO2013170256A1 Multiplexed microcolumn devices and processes for selection of nucleic acid aptamers |
11/14/2013 | WO2013170215A1 Methods for predicting and detecting cancer risk |
11/14/2013 | WO2013170201A2 Regulation of galactan synthase expression to modify galactan content in plants |
11/14/2013 | WO2013170174A1 Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signature |
11/14/2013 | WO2013170168A1 Multi-specific monoclonal antibodies |
11/14/2013 | WO2013170129A1 A system and method for automatically discovering, characterizing, classifying and semi-automatically labeling animal behavior and quantitative phenotyping of behaviors in animals |
11/14/2013 | WO2013170078A1 Adeno associated virus plasmids and vectors |
11/14/2013 | WO2013170071A1 Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations |
11/14/2013 | WO2013169929A1 Reducing immunogenicity of xenogeneic transplant tissues |
11/14/2013 | WO2013169923A2 Corn event mon 87411 |
11/14/2013 | WO2013169917A1 Clonal analysis of functional genomic assays and compositions for practicing same |
11/14/2013 | WO2013169867A1 Methods and compositions for rewritable digital data storage in live cells |
11/14/2013 | WO2013169861A1 Buffer for one-step dna extraction |
11/14/2013 | WO2013169802A1 Methods and compositions for nuclease-mediated targeted integration of transgenes |
11/14/2013 | WO2013169350A1 Biosynthetic pathways, recombinant cells, and methods |
11/14/2013 | WO2013169009A1 Plant for producing high-mannose n-glycan, and method for producing high-mannose n-glycan using same |
11/14/2013 | WO2013168924A1 Nucleic acid detection by oligonucleotide probes cleaved by both exonuclease and endonuclease |
11/14/2013 | WO2013168918A1 Anti-erbb2 antibody variants |
11/14/2013 | WO2013168908A1 Novel mutant l-arabitol dehydrogenase derived from neurospora crassa with enhanced activity |
11/14/2013 | WO2013168859A1 Method for discovering biomarkers |
11/14/2013 | WO2013168844A1 Method for detecting genes sensitive to low-level ionizing radiation, and gene detected by the method |
11/14/2013 | WO2013168832A1 Analysis kit for high-risk human papillomavirus genes, and analysis method therefor |
11/14/2013 | WO2013168829A1 Anti oncostatin m receptor beta antibody |
11/14/2013 | WO2013168826A1 Method for screening for prophylactic or therapeutic agent for diseases or disorders associated with inflammation-related feedback loop |
11/14/2013 | WO2013168820A1 Anti-cxadr antibody |
11/14/2013 | WO2013168644A1 Method for predicting prognosis of renal cell carcinoma |
11/14/2013 | WO2013168438A1 Protein having lactase activity, gene encoding said protein, recombinant vector carrying said gene, transformant, method for producing said protein, and use of said protein |
11/14/2013 | WO2013168310A1 Method for producing oxo fatty acid and rare fatty acid |
11/14/2013 | WO2013168181A1 Polynucleotide encoding catlp1 protein and uses thereof |
11/14/2013 | WO2013167902A1 Method for modifying lignin biosynthesis in plants |
11/14/2013 | WO2013167812A1 Method for producing terpenes |
11/14/2013 | WO2013167784A1 Miniuib minitransposon and derived uses |
11/14/2013 | WO2013167751A1 Triterpenoid sapogenin production in plant and microbial cultures |
11/14/2013 | WO2013167744A1 Rna products and uses thereof |
11/14/2013 | WO2013167471A1 Artificial forisome body with seo-f fusion proteins, plant or yeast cells comprising vectors which code for these proteins, as well as vectors which code for seo-f fusion proteins |
11/14/2013 | WO2013167265A1 Nucleic acid construct and use of the same |
11/14/2013 | WO2013166996A1 Gene improving the stress resistance of plants and use thereof |
11/14/2013 | WO2013166863A1 Preparation method of competent host cells and uses thereof |
11/14/2013 | WO2013166609A1 Rotavirus-like particle production in plants |
11/14/2013 | WO2013166604A1 Single-arm monovalent antibody constructs and uses thereof |
11/14/2013 | WO2013166558A1 Diagnostic gene marker panel for colorectal cancer |
11/14/2013 | WO2013138353A3 Compositions and methods for modulation of atxn3 expression |
11/14/2013 | WO2013137922A3 Functionalization and purification of molecules by reversible group exchange |
11/14/2013 | WO2013136057A3 Genes involved in noscapine production |